All investigators in the field of clinical pharmacy and clinical pharmacology, ACCP members and nonmembers alike, are invited to submit abstracts to be considered for presentation at the 2018 ACCP Global Conference on Clinical Pharmacy in Seattle, October 20–23.

All abstracts accepted for presentation, except for “Encore” and “Research-in-Progress” presentations, will have full-text abstracts published online in an official journal of ACCP. Only the abstract title, authors, and original citation will be published for “Encore” presentations. All accepted abstracts will be published full-text in the ACCP Annual Meeting app. Posters from all categories will be distributed across the poster display sessions/days throughout the meeting.

ABSTRACT CATEGORIES:

Original Research: Abstracts must summarize quantitative or qualitative findings from completed research. Basic, clinical, translational, dissemination/implementation, or educational research are examples of acceptable research. Topics should be relevant to a clinical pharmacy audience and may include research in drug metabolism, education/pedagogy, health services, medication safety, patient/population outcomes, pharmacokinetics, pharmacodynamics, pharmacoeconomics, pharmacoepidemiology, pharmacogenomics, pharmacology, or pharmacotherapy. Abstracts reporting in vitro or animal research are invited. Encore submissions are also welcome.

Systematic Reviews/Meta-Analyses: Abstracts must describe a systematic review adhering to the guidelines and definitions established by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and include the 12 items published in the PRISMA for Abstracts checklist.

Case Reports: Abstracts of case reports must update and expand therapeutic insights or generate research hypotheses. Although narrative in nature, these abstracts must stress the “evidence” for the authors’ conclusions by describing the process followed to understand the findings and possible mechanisms involved in the case, how patients were evaluated and treated, and specific descriptions of the outcome(s).

Clinical Pharmacy Forum: Abstracts must describe the delivery, justification, documentation, adaptability, and impact/significance of innovative clinical pharmacy services. Abstracts that address components of the ACCP Standards of Practice for Clinical Pharmacists and/or describe efforts to develop, advance, or position clinical pharmacists to optimize patient care are encouraged. Abstracts may be descriptive and need not contain an evaluative component. Encore submissions are welcome.

Advances in International Clinical Pharmacy Practice, Education, or Training: Abstracts must describe the delivery, justification, documentation, adaptability, and impact/significance of clinical pharmacy practice, education, or training outside the United States. Abstracts may be descriptive and need not contain an evaluative component.

Resident and Fellow Research-in-Progress: Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission. The presenting author must be in a postgraduate training program (PGY1 or PGY2 residency, Ph.D./master’s graduate degree program, or fellowship training program).

Student Research-in-Progress: Submission guidelines are those of an Original Research abstract except that the research effort is ongoing at the time of abstract submission. The presenting author must be a first professional degree (Pharm.D. or BSPharm) student.

Encore Presentation: Submission and evaluation criteria are those of the Original Research, Systematic Review/Meta-Analysis, Case Report, or Clinical Pharmacy Forum category, except that the same abstract was presented elsewhere or published in abstract form only before this meeting. Abstracts submitted for Encore Presentations must not be modified from the previously presented/published version. This includes the title, authors, and abstract body. The presenting author may differ, but he or she must be an author on the original abstract.

Important Dates:

• Early Decision
• The early decision abstract submission deadline for all abstract categories (Original Research; Systematic Reviews; Case Reports; Clinical Pharmacy Forum; Advances in International Clinical Pharmacy Practice, Education, or Training abstracts; and Research-in-Progress) is February 15, 2018.
• Authors will receive a notification of acceptance or declination by April 16, 2018.
• Regular Decision
• The regular decision abstract submission deadline for Original Research, Systematic Reviews, Case Reports, Clinical Pharmacy Forum, and Advances in International Clinical Pharmacy Practice, Education, or Training abstracts is June 15, 2018.
• The regular decision abstract submission deadline for Research-in-Progress abstracts (Student & Resident and Fellow) is July 15, 2018.
• Authors will receive a notification of acceptance or declination by August 15, 2018.

To review the complete submission instructions, guidelines, and review criteria, or to submit an abstract, visit the ACCP website.